CANC vs. IDHQ ETF Comparison
Comparison of Tema Oncology ETF (CANC) to PowerShares S&P International Developed High Quality Portfolio (IDHQ)
CANC
Tema Oncology ETF
CANC Description
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$26.52
Average Daily Volume
2,676
Number of Holdings
*
43
* may have additional holdings in another (foreign) market
IDHQ
PowerShares S&P International Developed High Quality Portfolio
IDHQ Description
The PowerShares S&P International Developed High Quality Portfolio (Fund) is based on the S&P International Developed High Quality Rankings Index ND (Index). The Fund generally will invest at least 90% of its total assets in companies that are identified by the Index as high quality stocks based on historical records of earnings and dividends. The Index is computed using the net return, which withholds applicable taxes for non-resident investors. The Fund and the Index are rebalanced and reconstituted bi-annually, in January and July.Grade (RS Rating)
Last Trade
$28.91
Average Daily Volume
54,757
Number of Holdings
*
9
* may have additional holdings in another (foreign) market
Performance
Period | CANC | IDHQ |
---|---|---|
30 Days | -6.12% | -5.89% |
60 Days | -9.26% | -7.59% |
90 Days | -11.21% | -9.42% |
12 Months | 15.05% | 7.93% |
1 Overlapping Holdings
Symbol | Grade | Weight in CANC | Weight in IDHQ | Overlap | |
---|---|---|---|---|---|
NVS | F | 2.03% | 5.32% | 2.03% |
CANC Overweight 42 Positions Relative to IDHQ
Symbol | Grade | Weight | |
---|---|---|---|
GILD | C | 5.49% | |
REGN | F | 5.25% | |
RVMD | C | 4.6% | |
ARGX | B | 4.19% | |
ILMN | C | 4.16% | |
INCY | C | 4.1% | |
BPMC | B | 4.05% | |
EXEL | B | 2.93% | |
MRK | D | 2.81% | |
AGIO | C | 2.71% | |
MREO | F | 2.54% | |
AMGN | F | 2.37% | |
BGNE | D | 2.3% | |
CRSP | D | 2.3% | |
SWTX | C | 2.14% | |
GH | B | 2.07% | |
NUVL | C | 1.99% | |
DAWN | D | 1.9% | |
GMAB | F | 1.84% | |
NTLA | F | 1.58% | |
ACLX | C | 1.5% | |
EXAS | D | 1.45% | |
CLDX | F | 1.44% | |
SDGR | C | 1.44% | |
JANX | C | 1.43% | |
LEGN | D | 1.41% | |
MRUS | F | 1.37% | |
LNTH | D | 1.22% | |
NRIX | C | 1.15% | |
COGT | D | 0.95% | |
IDYA | F | 0.9% | |
BNTX | C | 0.89% | |
BCYC | F | 0.84% | |
CGEM | F | 0.83% | |
ORIC | F | 0.76% | |
MRNA | F | 0.72% | |
RLAY | F | 0.69% | |
IMCR | D | 0.69% | |
RCUS | F | 0.67% | |
TERN | F | 0.6% | |
CGON | F | 0.56% | |
ARVN | F | 0.46% |
CANC: Top Represented Industries & Keywords
IDHQ: Top Represented Industries & Keywords
Industries:
Drug Manufacturers - Major
Auto Manufacturers
Beverages - Wineries & Distilleries
Household & Personal Products
Internet Retail
Railroads
Recreational Vehicles
Software - Application
Keywords:
Eye Care Products
Pharmaceutical
Active Pharmaceutical Ingredients
Adalimumab
Advanced Prostate Cancer
Alcohol
Alcoholic Drinks
Anemia
Animal Health
Antibiotics
Antivirus Software
Atopic Dermatitis
Autoimmune Disease
Automotive Manufacturers
Automotive Products
Beauty Products
Beer
Biotechnology
Blood Cancers
Blood Test